Used as a key intermediate in the synthesis of fluoroquinolone antibiotics. Its structure supports the formation of active pharmaceutical ingredients with broad-spectrum antibacterial activity, particularly against Gram-negative and some Gram-positive bacteria. The compound's fluorinated quinoline core enhances drug potency and bioavailability, making it valuable in developing antimicrobial agents for treating respiratory, urinary, and soft tissue infections. It is primarily utilized in controlled laboratory and industrial settings for drug development rather than direct therapeutic use.